{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:15:45Z","timestamp":1789848945731,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammatory bowel disease (IBD) is a refractory chronic inflammatory illness of the gastrointestinal (GI) tract. Macrophage exerts an important role in IBD development. QKI, as an RNA binding protein, was related with inflammatory responses in bacterial infections by regulating the polarization of macrophages. Therefore, we suspected that QKI-regulated macrophages have the potential to play a certain role in IBD and the underlying mechanism. Our results demonstrated that the mice with macrophage-specific deletion of <jats:italic>QKI<\/jats:italic> induced with dextran sodium sulfate (DSS) are more susceptible to IBD development, exhibited a severe leaky gut barrier phenotype and higher intense oxidative stress, which are rescued by treating with butylated hydroxyanisole (BHA), an agonist of NRF2. Mechanically, we observed that <jats:italic>Keap1<\/jats:italic> mRNA in the nucleus was exported to the cytoplasm after LPS stimuli in parallel with QKI reductions, and the removal of QKI by shRNA facilitated <jats:italic>Keap1<\/jats:italic> mRNA nuclear exporting and expression in cytoplasm, consequently NRF2 activation in nucleus was weakened, and led to the impaired antioxidant abilities. In addition, mice models of fecal microbiota transplant (FMT) and the co-culturing of mice epithelia cells with feces derived from the DSS-treated QKI-deficit mice revealed consistently aggravated colitis along with a severe oxidative stress; 16S sequencing analysis substantiated the altered compositions of commensal bacteria too. Overall, the current study represents the first effort to explore the anti-oxidant role of QKI in the intestinal macrophage via post-transcriptional regulation of <jats:italic>Keap1<\/jats:italic> mRNA localization and the relevant NRF2 antioxidant signaling, and the disproportional changes in the microbiota were attributable to the mediation of pathogenic damage in the IBD development of QKI-deficit mice.<\/jats:p>","DOI":"10.1038\/s41420-021-00444-w","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T08:02:50Z","timestamp":1616486570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Loss of QKI in macrophage aggravates inflammatory bowel disease through amplified ROS signaling and microbiota disproportion"],"prefix":"10.1038","volume":"7","author":[{"given":"Wenwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongquan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"444_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1634-x","volume":"10","author":"S-L Wang","year":"2019","unstructured":"Wang, S.-L. et al. Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel disease. Cell Death Dis. 10, 391 (2019).","journal-title":"Cell Death Dis."},{"key":"444_CR2","doi-asserted-by":"crossref","unstructured":"Giuffrida, P. & Sabatino, A. D. Targeting T cells in inflammatory bowel disease. Pharmacol. Res. 159, 105040 (2020).","DOI":"10.1016\/j.phrs.2020.105040"},{"key":"444_CR3","doi-asserted-by":"crossref","unstructured":"Leppkes, M. & Neurath, M. F. Cytokines in inflammatory bowel diseases - Update 2020. Pharmacol. Res. 158, 104835 (2020).","DOI":"10.1016\/j.phrs.2020.104835"},{"key":"444_CR4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/apt.15523","volume":"50","author":"S Lam","year":"2019","unstructured":"Lam, S. et al. Review article: fungal alterations in inflammatory bowel diseases. Aliment. Pharmacol. Ther. 50, 1159\u20131171 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"444_CR5","doi-asserted-by":"crossref","unstructured":"Lavelle, A. & Sokol, H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 223\u2013237 (2020).","DOI":"10.1038\/s41575-019-0258-z"},{"key":"444_CR6","doi-asserted-by":"crossref","unstructured":"Koelink, P. J. et al. Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling. Gut 69, 1053\u20131063 (2019).","DOI":"10.1136\/gutjnl-2019-318264"},{"key":"444_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.molmed.2011.05.011","volume":"17","author":"L Vereecke","year":"2011","unstructured":"Vereecke, L., Beyaert, R. & van Loo, G. Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol. Med. 17, 584\u2013593 (2011).","journal-title":"Trends Mol. Med."},{"key":"444_CR8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1136\/gutjnl-2012-303955","volume":"62","author":"MZ Cader","year":"2013","unstructured":"Cader, M. Z. & Kaser, A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 62, 1653\u20131664 (2013).","journal-title":"Gut"},{"key":"444_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","volume":"67","author":"F Imhann","year":"2018","unstructured":"Imhann, F. et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 67, 108\u2013119 (2018).","journal-title":"Gut"},{"key":"444_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00535-019-01618-1","volume":"55","author":"Y Mishima","year":"2020","unstructured":"Mishima, Y. & Sartor, R. B. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases. J. Gastroenterol. 55, 4\u201314 (2020).","journal-title":"J. Gastroenterol."},{"key":"444_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HS de Souza","year":"2016","unstructured":"de Souza, H. S. & Fiocchi, C. Immunopathogenesis of IBD: current state of the art. Nat. Rev. Gastroenterol. Hepatol. 13, 13\u201327 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"444_CR12","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic, A. D., Xavier, R. J. & Gevers, D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146, 1489\u20131499 (2014).","journal-title":"Gastroenterology"},{"key":"444_CR13","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00011-020-01398-y","volume":"69","author":"TC Moreira Lopes","year":"2020","unstructured":"Moreira Lopes, T. C., Mosser, D. M. & Gon\u00e7alves, R. Macrophage polarization in intestinal inflammation and gut homeostasis. Inflamm. Res. 69, 1163\u20131172 (2020).","journal-title":"Inflamm. Res."},{"key":"444_CR14","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3389\/fmicb.2020.01065","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang, J., Chen, W. D. & Wang, Y. D. The relationship between gut microbiota and inflammatory diseases: the role of macrophages. Front. Microbiol. 11, 1065 (2020).","journal-title":"Front. Microbiol."},{"key":"444_CR15","doi-asserted-by":"crossref","unstructured":"Han, L. et al. Beneficial effects of potentilla discolor bunge water extract on inflammatory cytokines release and gut microbiota in high-fat diet and streptozotocin-induced type 2 diabetic mice. Nutrients 11, 670 (2019).","DOI":"10.3390\/nu11030670"},{"key":"444_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.niox.2019.05.002","volume":"89","author":"Y Sui","year":"2019","unstructured":"Sui, Y., Tian, R. & Lu, N. NADPH oxidase is a primary target for antioxidant effects by inorganic nitrite in lipopolysaccharide-induced oxidative stress in mice and in macrophage cells. Nitric Oxide 89, 46\u201353 (2019).","journal-title":"Nitric Oxide"},{"key":"444_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma, Q. Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53, 401\u2013426 (2013).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"444_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2019.12.012","volume":"148","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis. Free Radic. Biol. Med. 148, 33\u201341 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"444_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.freeradbiomed.2020.03.023","volume":"157","author":"A Kopacz","year":"2020","unstructured":"Kopacz, A., Kloska, D., Forman, H. J., Jozkowicz, A. & Grochot-Przeczek, A. Beyond repression of Nrf2: An update on Keap1. Free Radic. Biol. Med. 157, 63\u201374 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"444_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/wrna.1344","volume":"7","author":"L Darbelli","year":"2016","unstructured":"Darbelli, L. & Richard, S. Emerging functions of the Quaking RNA-binding proteins and link to human diseases. Wiley Interdiscip. Rev. RNA 7, 399\u2013412 (2016).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"444_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nn1359","volume":"8","author":"D Larocque","year":"2005","unstructured":"Larocque, D. et al. Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation. Nat. Neurosci. 8, 27\u201333 (2005).","journal-title":"Nat. Neurosci."},{"key":"444_CR22","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1091\/mbc.e11-05-0412","volume":"23","author":"H Fu","year":"2012","unstructured":"Fu, H. et al. The RNA-binding protein QKI5 is a direct target of C\/EBPalpha and delays macrophage differentiation. Mol. Biol. Cell 23, 1628\u20131635 (2012).","journal-title":"Mol. Biol. Cell"},{"key":"444_CR23","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3389\/fimmu.2017.01754","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Quaking deficiency amplifies inflammation in experimental endotoxemia via the aryl hydrocarbon receptor\/signal transducer and activator of transcription 1-NF-kappaB pathway. Front. Immunol. 8, 1754 (2017).","journal-title":"Front. Immunol."},{"key":"444_CR24","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.3389\/fimmu.2018.02733","volume":"9","author":"CC Bain","year":"2018","unstructured":"Bain, C. C. & Schridde, A. Origin, differentiation, and function of intestinal macrophages. Front. Immunol. 9, 2733 (2018).","journal-title":"Front. Immunol."},{"key":"444_CR25","doi-asserted-by":"publisher","first-page":"107979","DOI":"10.1016\/j.celrep.2020.107979","volume":"32","author":"B Kaya","year":"2020","unstructured":"Kaya, B. et al. Lysophosphatidic acid-mediated GPR35 signaling in CX3CR1(+) macrophages regulates intestinal homeostasis. Cell Rep. 32, 107979 (2020).","journal-title":"Cell Rep."},{"key":"444_CR26","doi-asserted-by":"publisher","first-page":"2406594","DOI":"10.1155\/2018\/2406594","volume":"2018","author":"L Dumitrescu","year":"2018","unstructured":"Dumitrescu, L. et al. Oxidative stress and the microbiota-gut-brain axis. Oxid. Med. Cell. Longev. 2018, 2406594 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"444_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.01.003","volume":"63","author":"A Weigert","year":"2018","unstructured":"Weigert, A., von Knethen, A., Fuhrmann, D., Dehne, N. & Br\u00fcne, B. Redox-signals and macrophage biology. Mol. Aspects Med. 63, 70\u201387 (2018).","journal-title":"Mol. Aspects Med."},{"key":"444_CR28","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1172\/JCI123374","volume":"129","author":"J He","year":"2019","unstructured":"He, J. et al. Fbxw7 increases CCL2\/7 in CX3CR1hi macrophages to promote intestinal inflammation. J. Clin. Invest. 129, 3877\u20133893 (2019).","journal-title":"J. Clin. Invest."},{"key":"444_CR29","doi-asserted-by":"publisher","first-page":"4590127","DOI":"10.1155\/2017\/4590127","volume":"2017","author":"G Giardino","year":"2017","unstructured":"Giardino, G. et al. NADPH oxidase deficiency: a multisystem approach. Oxid. Med. Cell. Longev. 2017, 4590127 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"444_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-7151-0_2","volume":"1635","author":"H Souabni","year":"2017","unstructured":"Souabni, H., Ezzine, A., Bizouarn, T. & Baciou, L. Functional assembly of soluble and membrane recombinant proteins of mammalian NADPH oxidase complex. Methods Mol. Biol. 1635, 27\u201343 (2017).","journal-title":"Methods Mol. Biol."},{"key":"444_CR31","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1002\/jcp.29219","volume":"235","author":"P Shaw","year":"2020","unstructured":"Shaw, P. & Chattopadhyay, A. Nrf2-ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms. J. Cell Physiol. 235, 3119\u20133130 (2020).","journal-title":"J. Cell Physiol."},{"key":"444_CR32","doi-asserted-by":"crossref","unstructured":"Kasai, S., Shimizu, S., Tatara, Y., Mimura, J. & Itoh, K. Regulation of Nrf2 by mitochondrial reactive oxygen species in physiology and pathology. Biomolecules 10, 320 (2020).","DOI":"10.3390\/biom10020320"},{"key":"444_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/15548627.2019.1635384","volume":"16","author":"A Larabi","year":"2019","unstructured":"Larabi, A., Barnich, N. & Nguyen, H. T. T. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy 16, 38\u201351 (2019).","journal-title":"Autophagy"},{"key":"444_CR34","doi-asserted-by":"crossref","unstructured":"Khan, I. et al. Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens 8, 126 (2019).","DOI":"10.3390\/pathogens8030126"},{"key":"444_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"YZ Zhang","year":"2014","unstructured":"Zhang, Y. Z. & Li, Y. Y. Inflammatory bowel disease: pathogenesis. World J. Gastroenterol. 20, 91\u201399 (2014).","journal-title":"World J. Gastroenterol."},{"key":"444_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41575-018-0091-9","volume":"16","author":"NZ Borren","year":"2019","unstructured":"Borren, N. Z., van der Woude, C. J. & Ananthakrishnan, A. N. Fatigue in IBD: epidemiology, pathophysiology and management. Nat. Rev. Gastroenterol. Hepatol. 16, 247\u2013259 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"444_CR37","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3389\/fimmu.2017.01754","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Quaking deficiency amplifies inflammation in experimental endotoxemia via the aryl hydrocarbon receptor\/signal transducer and activator of transcription 1-NF-\u03baB pathway. Front. Immunol. 8, 1754 (2017).","journal-title":"Front. Immunol."},{"key":"444_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.taap.2015.08.006","volume":"288","author":"L Luo","year":"2015","unstructured":"Luo, L. et al. Butylated hydroxyanisole induces distinct expression patterns of Nrf2 and detoxification enzymes in the liver and small intestine of C57BL\/6 mice. Toxicol. Appl. Pharmacol. 288, 339\u2013348 (2015).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"444_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cca.2019.12.010","volume":"503","author":"H Antushevich","year":"2020","unstructured":"Antushevich, H. Fecal microbiota transplantation in disease therapy. Clin. Chim. Acta 503, 90\u201398 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"444_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pharmthera.2019.03.006","volume":"199","author":"K Uchiyama","year":"2019","unstructured":"Uchiyama, K., Naito, Y. & Takagi, T. Intestinal microbiome as a novel therapeutic target for local and systemic inflammation. Pharmacol. Ther. 199, 164\u2013172 (2019).","journal-title":"Pharmacol. Ther."},{"key":"444_CR41","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/mi.2015.49","volume":"8","author":"M Sun","year":"2015","unstructured":"Sun, M., He, C., Cong, Y. & Liu, Z. Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal Immunol. 8, 969\u2013978 (2015).","journal-title":"Mucosal Immunol."},{"key":"444_CR42","doi-asserted-by":"crossref","unstructured":"de Souza-Basqueira, M. et al. Gut dysbiosis in chagas disease. a possible link to the pathogenesis. Front. Cell. Infect. Microbiol. 10 (2020).","DOI":"10.3389\/fcimb.2020.00402"},{"key":"444_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11938-019-00221-w","volume":"17","author":"NC Knox","year":"2019","unstructured":"Knox, N. C., Forbes, J. D., Van Domselaar, G. & Bernstein, C. N. The gut microbiome as a target for IBD treatment: are we there yet? Curr. Treat. Options Gastroenterol. 17, 115\u2013126 (2019).","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"444_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-62703-604-7_7","volume":"1066","author":"JC Ibla","year":"2013","unstructured":"Ibla, J. C. & Khoury, J. Methods to assess tissue permeability. Methods Mol. Biol. 1066, 81\u201388 (2013).","journal-title":"Methods Mol. Biol."}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-021-00444-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-021-00444-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-021-00444-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:32:23Z","timestamp":1669973543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-021-00444-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1038\/s41420-021-00444-w","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"15 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"58"}}